Park Ha Biological Tech
BYAHPark Ha Biological Tech (BYAH)
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China. It operates in two segments,...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Daily Events
- Jul, 2
Park Ha Biological Technology experienced a sharp decline during regular trading, with the stock at $0.8541 as of ET 11:00, down 7.21% from the previous close of $0.9205, primarily driven by a combination of negative catalysts. The company announced partnerships with Amazon to enter the North American personal care market and with Cloud Factory for an AI-driven beauty platform, yet the stock continued to slide following a 41% after-hours surge, and the recent $2.0 million registered direct offering raises dilution concerns. Its Q4 2025 revenue fell 15.91% YoY to $642,823, while net loss widened 1154% to $2.26 million, with an EPS of -$3.54, highlighting deteriorating fundamentals. The current price sits 97.94% below the 52-week high of $41.49 but is up 402.12% year-to-date, and remains below its 20-day and 60-day moving averages of $1.306 and $1.208, reflecting weak technical positioning. However, after-hours trading saw a rebound to $0.9142, suggesting some short-term speculative interest.
